Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies.
N K Cheung(Memorial Sloan Kettering Cancer Center), Peter F. Coccia(North Central Cancer Treatment Group), Daniel D. Von Hoff(Translational Genomics Research Institute), Sarah E. Strandjord(Memorial Sloan Kettering Cancer Center)
Cited by 78
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
|Annals of Oncology|1996|569
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
|Nature Communications|2015|484
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
|Journal of Clinical Oncology|1987|417